Table 2.
Peripheral sensory neuropathy (grades in CTCAEv4.0) after different courses of XELOX treatment.
| Patients number | 1 course | 2 course | 3 course | 4 course | 5 course | 6 course | 7 course | 8 course | 5 years |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 2 | 1 | 1 | 1 | 1 | Stop | 3 | |
| 2 | 0 | Stop | 2 | ||||||
| 3 | 1 | Stop | 1 | ||||||
| 4 | 1 | 2 | 2 | Stop | 1 | ||||
| 5 | 0 | 0 | 0 | 0 | Stop | 1 | |||
| 6 | 1 | 1 | 1 | 1 | Stop | 1 | |||
| 7 | 1 | 1 | 1 | 1 | 1 | 1 | Stop | 1 | |
| 8 | 0 | 2 | 2 | 1 | 1 | 1 | 1 | Stop | 1 |
| 9 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | Stop | 1 |
| 10 | 0 | 0 | 1 | 1 | 1 | 1 | 3 | Stop | 1 |
| 11 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 |
| 12 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| 13 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 0 | 1 |
| 14 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 15 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| 16 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 17 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| 18 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 19 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 20 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 21 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 22 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| 23 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |